Physician profile
Jane Lyons
NPI 1861492753
$339.91
in general payments reported to CMS, 2019-2025
12 companies · $60.74 in 2025
The $60.74 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.71 · 2020: $38.32 · 2021: $14.61 · 2022: $53.28 · 2023: $66.04 · 2024: $60.21 · 2025: $60.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $60.76 | 2019-2025 | |
| Hologic Sales and Service, LLC | $52.45 | 2022-2023 | Acessa Provu System, Coolseal Generator |
| Organon LLC | $38.30 | 2022-2025 | Nexplanon |
| Biogen, INC. | $30.74 | 2025 | Zurzuvae |
| Abbvie INC. | $29.64 | 2023 | |
| Covidien LP | $26.87 | 2019-2020 | |
| Coopersurgical, INC. | $25.75 | 2022-2024 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $18.14 | 2024 | Gardasil, Gardasil 9 |
| Vertex Pharmaceuticals Incorporated | $14.96 | 2024 | |
| Myovant Sciences INC. | $14.61 | 2021 | |
| Exeltis, USA INC. | $13.88 | 2022 | |
| Therapeuticsmd, INC. | $13.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.